Ji‐chun Ma

2.2k total citations
102 papers, 1.6k citations indexed

About

Ji‐chun Ma is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Ji‐chun Ma has authored 102 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 75 papers in Hematology and 32 papers in Cancer Research. Recurrent topics in Ji‐chun Ma's work include Acute Myeloid Leukemia Research (71 papers), Epigenetics and DNA Methylation (39 papers) and Cancer-related gene regulation (22 papers). Ji‐chun Ma is often cited by papers focused on Acute Myeloid Leukemia Research (71 papers), Epigenetics and DNA Methylation (39 papers) and Cancer-related gene regulation (22 papers). Ji‐chun Ma collaborates with scholars based in China, United States and Canada. Ji‐chun Ma's co-authors include Jiang Lin, Jun Qian, Xiang‐mei Wen, Jing‐dong Zhou, Zi‐jun Xu, Zhaoqun Deng, Ting‐juan Zhang, Dong‐ming Yao, Jing Yang and Jun Qian and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ji‐chun Ma

99 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ji‐chun Ma China	23	1.3k	728	642	201	163	102	1.6k
Antonio Jiménez‐Velasco Spain	25	1.1k 0.9×	713 1.0×	573 0.9×	218 1.1×	254 1.6×	52	1.9k
Haruko Shima Japan	13	505 0.4×	593 0.8×	307 0.5×	207 1.0×	190 1.2×	34	1.2k
Tiziana Palumbo United States	13	1.6k 1.3×	403 0.6×	1.4k 2.1×	197 1.0×	199 1.2×	17	2.1k
Allison Mayle United States	10	788 0.6×	462 0.6×	174 0.3×	204 1.0×	141 0.9×	13	1.1k
Laura F. Newell United States	18	686 0.5×	785 1.1×	147 0.2×	298 1.5×	251 1.5×	70	1.5k
Mu Hao China	20	759 0.6×	607 0.8×	289 0.5×	164 0.8×	407 2.5×	97	1.2k
Dengli Hong China	17	684 0.5×	516 0.7×	217 0.3×	457 2.3×	303 1.9×	30	1.5k
B. Masella Italy	12	890 0.7×	381 0.5×	282 0.4×	233 1.2×	221 1.4×	14	1.3k
Sagi Abelson Canada	12	520 0.4×	290 0.4×	213 0.3×	176 0.9×	204 1.3×	27	866
Yasuhiko Miyata Japan	15	702 0.6×	379 0.5×	142 0.2×	172 0.9×	277 1.7×	31	1.2k

Countries citing papers authored by Ji‐chun Ma

Since Specialization

Citations

This map shows the geographic impact of Ji‐chun Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji‐chun Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji‐chun Ma more than expected).

Fields of papers citing papers by Ji‐chun Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ji‐chun Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji‐chun Ma. The network helps show where Ji‐chun Ma may publish in the future.

Co-authorship network of co-authors of Ji‐chun Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Ji‐chun Ma. A scholar is included among the top collaborators of Ji‐chun Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ji‐chun Ma. Ji‐chun Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wen, Xiang‐mei, Zi‐jun Xu, Ji‐chun Ma, et al.. (2025). Bioinformatic characterization of STING expression in hematological malignancies reveals association with prognosis and anti-tumor immunity. Frontiers in Immunology. 16. 1477100–1477100. 1 indexed citations

Ma, Ji‐chun, Xiang‐mei Wen, Zi‐jun Xu, et al.. (2023). Abnormal regulation of miR-29b-ID1 signaling is involved in the process of decitabine resistance in leukemia cells. Cell Cycle. 22(10). 1215–1231. 4 indexed citations

Zhang, Ting‐juan, Zi‐jun Xu, Xiang‐mei Wen, et al.. (2022). SLIT2 promoter hypermethylation-mediated SLIT2-IT1/miR-218 repression drives leukemogenesis and predicts adverse prognosis in myelodysplastic neoplasm. Leukemia. 36(10). 2488–2498. 12 indexed citations

Gu, Yu, Zi‐jun Xu, Jing‐dong Zhou, et al.. (2021). Abnormal expression and methylation of PRR34‐AS1 are associated with adverse outcomes in acute myeloid leukemia. Cancer Medicine. 10(15). 5283–5296. 5 indexed citations

Zhang, Ting‐juan, Zi‐jun Xu, Yu Gu, et al.. (2021). Identification and validation of obesity-related gene LEP methylation as a prognostic indicator in patients with acute myeloid leukemia. Clinical Epigenetics. 13(1). 16–16. 14 indexed citations

Zhang, Ting‐juan, Zi‐jun Xu, Yu Gu, et al.. (2020). Identification and validation of prognosis‐related DLX5 methylation as an epigenetic driver in myeloid neoplasms. SHILAP Revista de lepidopterología. 10(2). e29–e29. 28 indexed citations

Zhang, Ting‐juan, Xiang‐mei Wen, Jing‐dong Zhou, et al.. (2019). SOX30 methylation correlates with disease progression in patients with chronic myeloid leukemia. OncoTargets and Therapy. Volume 12. 4789–4794. 9 indexed citations

Zhang, Ting‐juan, Zi‐jun Xu, Yu Gu, et al.. (2019). EZH2 dysregulation: Potential biomarkers predicting prognosis and guiding treatment choice in acute myeloid leukaemia. Journal of Cellular and Molecular Medicine. 24(2). 1640–1649. 10 indexed citations

Tang, Li‐Juan, Jing‐dong Zhou, Zi‐jun Xu, et al.. (2019). DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia. Cancer Medicine. 8(14). 6393–6402. 3 indexed citations

10.

Zhou, Jing‐dong, Ting‐juan Zhang, Zi‐jun Xu, et al.. (2019). BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia. Diagnostic Pathology. 14(1). 68–68. 60 indexed citations

11.

Yang, Lan, Jing‐dong Zhou, Ting‐juan Zhang, et al.. (2018). Overexpression of lncRNA PANDAR predicts adverse prognosis in acute myeloid leukemia. Cancer Management and Research. Volume 10. 4999–5007. 30 indexed citations

12.

Zhang, Zhihui, Wei Zhang, Jing‐dong Zhou, et al.. (2018). Decreased SCIN expression, associated with promoter methylation, is a valuable predictor for prognosis in acute myeloid leukemia. Molecular Carcinogenesis. 57(6). 735–744. 11 indexed citations

13.

Zhou, Jing‐dong, Jiang Lin, Ting‐juan Zhang, et al.. (2017). Hypomethylation‐mediated H19 overexpression increases the risk of disease evolution through the association with BCR‐ABL transcript in chronic myeloid leukemia. Journal of Cellular Physiology. 233(3). 2444–2450. 24 indexed citations

14.

Zhang, Ting‐juan, Jing‐dong Zhou, Xixi Li, et al.. (2017). Overexpression of miR‐216b: Prognostic and predictive value in acute myeloid leukemia. Journal of Cellular Physiology. 233(4). 3274–3281. 15 indexed citations

15.

Zhou, Jing‐dong, Ting‐juan Zhang, Xi-xi Li, et al.. (2017). Methylation‐independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia. Journal of Cellular Physiology. 233(6). 4707–4714. 6 indexed citations

16.

Yang, Jing, Dong‐ming Yao, Ji‐chun Ma, et al.. (2016). The prognostic implication of SRSF2 mutations in Chinese patients with acute myeloid leukemia. Tumor Biology. 37(8). 10107–10114. 19 indexed citations

17.

Guo, Hong, Jiang Lin, Jing Yang, et al.. (2014). Decreased SFRP2 expression is associated with intermediate and poor karyotypes in de novo acute myeloid leukemia.. PubMed. 7(8). 4695–703. 5 indexed citations

18.

Ma, Ji‐chun, Jiang Lin, Jun Qian, et al.. (2014). MiR-378 Promotes the Migration of Liver Cancer Cells by Down-Regulating Fus Expression. Cellular Physiology and Biochemistry. 34(6). 2266–2274. 41 indexed citations

19.

Chai, Hai‐yan, Jun Qian, Jiang Lin, et al.. (2013). [Expression of RAGE-1 gene in acute myeloid leukemia].. PubMed. 21(1). 20–4. 1 indexed citations

20.

Lin, Jiang, Jun Qian, Zhaoqun Deng, et al.. (2013). The Methylation Status of the DDX43 Promoter in Chinese Patients with Chronic Myeloid Leukemia. Genetic Testing and Molecular Biomarkers. 17(6). 508–511. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact